Stoke Therapeutics Inc (NASDAQ:STOK)
| 18.12 Delayed Data As of Jan 21 |  -0.02 / -0.11%Today’s Change | 17.71 Today|||52-Week Range 69.52 | -24.47% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Ticho Barry S Chief Medical Officer |  Sale | 7/13/2021 | 39,866 | $32.68 | $1.3M | -44.61% |
Tulipano Stephen J Chief Financial Officer | Sale | 2/22/2021 | 15,202 | $58.67 | $891.9K | -69.01% |
Tzianabos Arthur O Director | Sale | 2/19/2021 | 10,000 | $60.67 | $606.7K | -70.26% |
Tulipano Stephen J Chief Financial Officer | Sale | 2/22/2021 | 9,696 | $59.29 | $574.9K | -69.01% |
Levin Arthur A Director | Sale | 3/01/2021 | 7,543 | $60.55 | $456.7K | -70.40% |
Levin Arthur A Director | Sale | 3/01/2021 | 4,957 | $61.14 | $303.1K | -70.40% |
Tulipano Stephen J Chief Financial Officer | Sale | 2/23/2021 | 5,000 | $58.60 | $293.0K | -69.46% |
Nash Huw M | Sale | 7/01/2021 | 5,700 | $33.33 | $190.0K | -46.89% |
Liau Gene | Sale | 3/02/2021 | 2,900 | $63.52 | $184.2K | -69.83% |
Nash Huw M | Sale | 8/02/2021 | 5,700 | $28.87 | $164.6K | -37.28% |
Page of 4